Carnitine Analog [EPC]

Carnitine Analog [EPC] was reported 3682 times

Drugs of the Carnitine Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DYSGLOBULINAEMIA 3 0.1500
1 KERATOUVEITIS 5 0.1351
2 MITOCHONDRIAL DNA DEPLETION 3 0.0857
3 HYPERAMMONAEMIC CRISIS 8 0.0748
4 MYOFASCITIS 3 0.0361
5 BASAL GANGLIA STROKE 5 0.0347
6 CARNITINE DEFICIENCY 5 0.0292
7 ZINC DEFICIENCY 5 0.0233
8 SEIZURE CLUSTER 19 0.0229
9 VAGAL NERVE STIMULATOR IMPLANTATION 6 0.0196
10 ANTICONVULSANT DRUG LEVEL ABNORMAL 3 0.0170
11 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 4 0.0159
12 CHANGE IN SEIZURE PRESENTATION 10 0.0155
13 RETINOGRAM ABNORMAL 4 0.0149
14 AMMONIA ABNORMAL 6 0.0149
15 UREAPLASMA INFECTION 6 0.0147
16 SHUNT MALFUNCTION 4 0.0141
17 MELAS SYNDROME 3 0.0139
18 AMINO ACID LEVEL INCREASED 10 0.0135
19 MITRAL VALVE THICKENING 4 0.0134
20 PACKAGING DESIGN ISSUE 4 0.0122
21 HYPERAMMONAEMIA 58 0.0116
22 MITOCHONDRIAL CYTOPATHY 5 0.0114
23 HYPOPHOSPHATAEMIC OSTEOMALACIA 3 0.0114
24 MITOCHONDRIAL TOXICITY 9 0.0110
25 ATONIC SEIZURES 9 0.0105
26 PRODUCT BARCODE ISSUE 4 0.0104
27 DEFIANT BEHAVIOUR 3 0.0097
28 INFANTILE SPASMS 7 0.0097
29 ENTEROVIRUS INFECTION 8 0.0093
30 UPPER RESPIRATORY TRACT INFLAMMATION 11 0.0092
31 RHINOVIRUS INFECTION 34 0.0087
32 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
33 ARTERIOVENOUS FISTULA SITE COMPLICATION 5 0.0083
34 FEEDING TUBE USER 3 0.0082
35 SPONTANEOUS HAEMATOMA 6 0.0080
36 NECROTISING OESOPHAGITIS 4 0.0080
37 ACETONAEMIA 2 0.0079
38 DILATED CARDIOMYOPATHY 8 0.0079
39 BLOOD MAGNESIUM INCREASED 7 0.0078
40 TONIC CONVULSION 11 0.0078
41 AMMONIA INCREASED 39 0.0076
42 BLOOD HOMOCYSTEINE INCREASED 3 0.0070
43 MYOCLONIC EPILEPSY 10 0.0066
44 INSULIN-LIKE GROWTH FACTOR INCREASED 9 0.0063
45 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 4 0.0062
46 STARVATION 5 0.0060
47 GASTROINTESTINAL VIRAL INFECTION 6 0.0058
48 DERMATITIS DIAPER 4 0.0057
49 PRODUCT PREPARATION ISSUE 36 0.0055
50 AORTIC VALVE SCLEROSIS 4 0.0055
51 OTITIS MEDIA ACUTE 4 0.0054
52 SMALL FIBRE NEUROPATHY 4 0.0054
53 BLOOD PH INCREASED 3 0.0054
54 SERRATIA INFECTION 4 0.0054
55 BURNOUT SYNDROME 3 0.0053
56 TRACHEITIS 4 0.0052
57 HYPERAMMONAEMIC ENCEPHALOPATHY 9 0.0052
58 METAPNEUMOVIRUS INFECTION 4 0.0051
59 ESCHERICHIA BACTERAEMIA 12 0.0051
60 CHOROIDAL EFFUSION 4 0.0050
61 PULMONARY VALVE INCOMPETENCE 7 0.0048
62 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2 0.0048
63 GASTROSTOMY 7 0.0045
64 AORTIC DILATATION 5 0.0045
65 VENTRICULAR HYPOKINESIA 14 0.0044
66 METABOLIC ENCEPHALOPATHY 13 0.0043
67 PROPOFOL INFUSION SYNDROME 3 0.0043
68 INCISION SITE PAIN 5 0.0043
69 NEPHROCALCINOSIS 5 0.0042
70 DYSLALIA 3 0.0041
71 B-CELL TYPE ACUTE LEUKAEMIA 3 0.0041
72 ORTHOPNOEA 13 0.0041
73 CYTOMEGALOVIRUS ENTEROCOLITIS 3 0.0039
74 STATUS EPILEPTICUS 44 0.0039
75 BILIRUBIN CONJUGATED INCREASED 9 0.0038
76 BLOOD KETONE BODY INCREASED 3 0.0038
77 HYPERLACTACIDAEMIA 10 0.0037
78 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 14 0.0037
79 HAND-FOOT-AND-MOUTH DISEASE 3 0.0036
80 DYSCHROMATOPSIA 3 0.0036
81 FANCONI SYNDROME 5 0.0035
82 BLOOD FIBRINOGEN DECREASED 4 0.0035
83 SEIZURE 400 0.0035
84 FOOD REFUSAL 3 0.0034
85 STEROID DEPENDENCE 3 0.0034
86 CARDIAC FAILURE CHRONIC 14 0.0033
87 METABOLIC DISORDER 19 0.0033
88 BEHAVIOUR DISORDER 17 0.0031
89 RED BLOOD CELLS URINE POSITIVE 3 0.0031
90 ANION GAP INCREASED 4 0.0030
91 LYMPHOCYTIC INFILTRATION 3 0.0030
92 VARICELLA 7 0.0029
93 RENAL ARTERY STENOSIS 4 0.0029
94 PERTUSSIS 3 0.0029
95 CHRONIC FATIGUE SYNDROME 4 0.0029
96 VASCULAR DEVICE INFECTION 13 0.0029
97 GALLBLADDER ENLARGEMENT 3 0.0028
98 ENTEROCOLITIS 16 0.0028
99 ADENOVIRUS INFECTION 8 0.0028
100 TRICUSPID VALVE INCOMPETENCE 21 0.0026
101 HYPOPROTEINAEMIA 5 0.0026
102 BRAIN OPERATION 6 0.0026
103 PNEUMONIA PSEUDOMONAL 4 0.0026
104 CARBON DIOXIDE DECREASED 3 0.0026
105 FOLATE DEFICIENCY 3 0.0026
106 MEAN CELL VOLUME DECREASED 4 0.0026
107 BICYTOPENIA 5 0.0025
108 ELECTROENCEPHALOGRAM ABNORMAL 8 0.0025
109 DEVICE RELATED SEPSIS 5 0.0025
110 ANTICONVULSANT DRUG LEVEL INCREASED 4 0.0025
111 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
112 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
113 BRONCHIAL SECRETION RETENTION 3 0.0024
114 NOCTURNAL DYSPNOEA 3 0.0024
115 APPLICATION SITE WARMTH 3 0.0024
116 DROOLING 16 0.0023
117 RENAL TUBULAR ACIDOSIS 5 0.0023
118 LIP INJURY 3 0.0023
119 DRUG WITHDRAWAL CONVULSIONS 4 0.0022
120 GENERALISED TONIC-CLONIC SEIZURE 37 0.0022
121 GLYCOSURIA 3 0.0022
122 CARBON DIOXIDE INCREASED 3 0.0022
123 SIALOADENITIS 3 0.0022
124 CONGESTIVE CARDIOMYOPATHY 9 0.0022
125 MECHANICAL VENTILATION 4 0.0021
126 EPILEPSY 64 0.0021
127 NOROVIRUS INFECTION 3 0.0021
128 OCULAR HYPERTENSION 4 0.0021
129 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
130 CARDIOPULMONARY FAILURE 8 0.0020
131 HEPATIC ENCEPHALOPATHY 19 0.0020
132 APLASIA PURE RED CELL 7 0.0020
133 KNEE DEFORMITY 3 0.0020
134 TACHYPNOEA 27 0.0020
135 NEPHROGENIC SYSTEMIC FIBROSIS 6 0.0020
136 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
137 SCOLIOSIS 12 0.0019
138 PRODUCT ADMINISTRATION INTERRUPTED 15 0.0019
139 NEUROGENIC BLADDER 4 0.0019
140 PNEUMONIA VIRAL 6 0.0019
141 KIDNEY TRANSPLANT REJECTION 9 0.0019
142 METABOLIC ALKALOSIS 3 0.0019
143 HYPERPHOSPHATAEMIA 4 0.0019
144 CLONUS 5 0.0018
145 DEVICE RELATED INFECTION 28 0.0018
146 TROPONIN I INCREASED 3 0.0018
147 SEIZURE LIKE PHENOMENA 3 0.0018
148 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
149 PETIT MAL EPILEPSY 9 0.0018
150 HAEMOLYTIC URAEMIC SYNDROME 4 0.0017
151 RESPIRATORY SYNCYTIAL VIRUS INFECTION 15 0.0017
152 PARTIAL SEIZURES 9 0.0017
153 FANCONI SYNDROME ACQUIRED 3 0.0017
154 PRESCRIBED UNDERDOSE 34 0.0017
155 GASTROINTESTINAL OEDEMA 3 0.0017
156 MYOPIA 4 0.0017
157 APPLICATION SITE DISCOMFORT 3 0.0017
158 GASTROENTERITIS VIRAL 30 0.0017
159 HYPERCAPNIA 5 0.0017
160 CENTRAL VENOUS CATHETERISATION 5 0.0017
161 STARING 4 0.0017
162 LOBAR PNEUMONIA 3 0.0016
163 HYPERVOLAEMIA 8 0.0016
164 MULTIPLE-DRUG RESISTANCE 5 0.0016
165 PROTEIN TOTAL DECREASED 6 0.0016
166 NARCOLEPSY 3 0.0016
167 MYELOPATHY 3 0.0016
168 BLOOD CHLORIDE DECREASED 4 0.0015
169 ADJUSTMENT DISORDER 2 0.0015
170 PYELONEPHRITIS ACUTE 3 0.0015
171 SKIN ODOUR ABNORMAL 6 0.0015
172 OTITIS MEDIA 5 0.0015
173 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
174 SKIN PAPILLOMA 6 0.0015
175 HYPOPHOSPHATAEMIA 11 0.0015
176 BLOOD SODIUM INCREASED 4 0.0015
177 BRADYPNOEA 4 0.0015
178 PNEUMONIA ASPIRATION 37 0.0015
179 HYPERURICAEMIA 6 0.0015
180 ACCIDENTAL POISONING 2 0.0015
181 BODY TEMPERATURE FLUCTUATION 3 0.0014
182 ACIDOSIS 11 0.0014
183 BRONCHIOLITIS 5 0.0014
184 MITRAL VALVE INCOMPETENCE 16 0.0014
185 AORTIC VALVE INCOMPETENCE 6 0.0014
186 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
187 ANAEMIA MACROCYTIC 3 0.0014
188 PROTEIN URINE PRESENT 7 0.0014
189 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
190 LIVER TRANSPLANT 5 0.0014
191 BLOOD UREA INCREASED 23 0.0014
192 AMYLASE INCREASED 5 0.0014
193 CARDIAC FAILURE ACUTE 9 0.0013
194 ATYPICAL PNEUMONIA 4 0.0013
195 COMPLICATIONS OF TRANSPLANTED KIDNEY 3 0.0013
196 PERIARTHRITIS 3 0.0013
197 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0013
198 DIASTOLIC DYSFUNCTION 4 0.0013
199 INFUSION SITE EXTRAVASATION 8 0.0013
200 BLOOD CREATININE DECREASED 4 0.0013
201 BLOOD ALBUMIN DECREASED 10 0.0013
202 STREPTOCOCCAL INFECTION 7 0.0013
203 LACUNAR INFARCTION 3 0.0013
204 METABOLIC ACIDOSIS 40 0.0012
205 BREATH ODOUR 3 0.0012
206 MYOSITIS 11 0.0012
207 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
208 HYPERNATRAEMIA 6 0.0012
209 HYPOTONIA 12 0.0012
210 HYPERPARATHYROIDISM SECONDARY 3 0.0012
211 SPINAL PAIN 14 0.0012
212 APPENDICITIS PERFORATED 3 0.0012
213 BACTERAEMIA 14 0.0012
214 SEDATION COMPLICATION 3 0.0012
215 NEUTROPHIL COUNT INCREASED 12 0.0012
216 APNOEA 9 0.0012
217 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
218 AORTIC STENOSIS 4 0.0011
219 ALOPECIA AREATA 2 0.0011
220 BLOOD LACTIC ACID INCREASED 6 0.0011
221 SERUM FERRITIN INCREASED 6 0.0011
222 WHITE BLOOD CELL DISORDER 3 0.0011
223 PRODUCT SUPPLY ISSUE 8 0.0011
224 DEVELOPMENTAL DELAY 10 0.0011
225 SCREAMING 7 0.0011
226 ASPIRATION 12 0.0011
227 AUTISM SPECTRUM DISORDER 6 0.0011
228 PRESCRIBED OVERDOSE 21 0.0011
229 IRON DEFICIENCY ANAEMIA 10 0.0011
230 MALNUTRITION 12 0.0011
231 LUNG CONSOLIDATION 3 0.0011
232 ENDOTRACHEAL INTUBATION 3 0.0011
233 PULMONARY CONGESTION 14 0.0011
234 RESPIRATORY SYMPTOM 3 0.0011
235 ATELECTASIS 10 0.0010
236 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
237 LUMBAR SPINAL STENOSIS 3 0.0010
238 MULTIPLE ORGAN DYSFUNCTION SYNDROME 29 0.0010
239 PULMONARY HAEMORRHAGE 8 0.0010
240 STRABISMUS 3 0.0010
241 CEREBRAL ATROPHY 4 0.0010
242 HYPERPHAGIA 4 0.0010
243 VARICES OESOPHAGEAL 3 0.0010
244 VIRAL INFECTION 33 0.0010
245 ENURESIS 4 0.0010
246 EMERGENCY CARE 3 0.0010
247 PNEUMONIA BACTERIAL 9 0.0010
248 PORTAL HYPERTENSION 3 0.0010
249 FAILURE TO THRIVE 5 0.0010
250 GASTROENTERITIS 14 0.0010
251 SLEEP TERROR 4 0.0009
252 OBESITY 15 0.0009
253 RETCHING 20 0.0009
254 HAEMODYNAMIC INSTABILITY 7 0.0009
255 URINE OUTPUT DECREASED 8 0.0009
256 SHOCK 21 0.0009
257 SUSPECTED COVID-19 3 0.0009
258 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
259 COAGULOPATHY 15 0.0009
260 RHINITIS ALLERGIC 4 0.0009
261 SUDDEN CARDIAC DEATH 3 0.0009
262 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
263 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
264 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
265 GRAND MAL CONVULSION 8 0.0009
266 HEPATIC FAILURE 26 0.0009
267 POST PROCEDURAL INFECTION 7 0.0009
268 HYPOPHAGIA 22 0.0009
269 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
270 ENCEPHALOPATHY 21 0.0009
271 HYPERTRIGLYCERIDAEMIA 5 0.0009
272 TIBIA FRACTURE 4 0.0009
273 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
274 HAND FRACTURE 6 0.0008
275 SKIN ABRASION 4 0.0008
276 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
277 SINUS TACHYCARDIA 12 0.0008
278 MYOCLONUS 10 0.0008
279 HYPERSOMNIA 24 0.0008
280 HYPERLIPIDAEMIA 10 0.0008
281 CHOLESTASIS 16 0.0008
282 ABNORMAL BEHAVIOUR 33 0.0008
283 BLOOD PHOSPHORUS DECREASED 3 0.0008
284 VITAMIN D DEFICIENCY 8 0.0008
285 FOOD INTOLERANCE 3 0.0008
286 THROMBOCYTOSIS 3 0.0008
287 BLOOD BILIRUBIN INCREASED 22 0.0008
288 ILEUS 10 0.0008
289 SECRETION DISCHARGE 10 0.0008
290 BLOOD CALCIUM INCREASED 7 0.0008
291 PRODUCT PRESCRIBING ERROR 19 0.0008
292 FACE INJURY 3 0.0008
293 EAR INFECTION 21 0.0008
294 HEPATOCELLULAR CARCINOMA 6 0.0008
295 LIPASE INCREASED 6 0.0008
296 RESPIRATORY FAILURE 57 0.0008
297 INCREASED UPPER AIRWAY SECRETION 4 0.0008
298 HYPERBILIRUBINAEMIA 8 0.0008
299 HYPOALBUMINAEMIA 6 0.0008
300 RHABDOMYOLYSIS 32 0.0008
301 HYPOXIA 27 0.0008
302 FOOD CRAVING 4 0.0008
303 CORONAVIRUS INFECTION 5 0.0008
304 PRODUCT DISTRIBUTION ISSUE 7 0.0008
305 MENINGITIS 5 0.0007
306 MUSCLE HAEMORRHAGE 3 0.0007
307 ADRENAL INSUFFICIENCY 9 0.0007
308 HYPERGLYCAEMIA 27 0.0007
309 MUSCLE DISORDER 6 0.0007
310 WRONG PRODUCT ADMINISTERED 5 0.0007
311 ABDOMINAL RIGIDITY 2 0.0007
312 LYMPHOCYTE COUNT DECREASED 13 0.0007
313 PERIPHERAL VENOUS DISEASE 3 0.0007
314 RESPIRATORY DEPRESSION 9 0.0007
315 TIC 4 0.0007
316 RESPIRATORY TRACT INFECTION 19 0.0007
317 AFFECT LABILITY 7 0.0007
318 GENERALISED OEDEMA 9 0.0007
319 RESPIRATORY DISTRESS 20 0.0007
320 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
321 ASCITES 21 0.0007
322 ANAL HAEMORRHAGE 2 0.0007
323 ACUTE PULMONARY OEDEMA 4 0.0007
324 HEPATOMEGALY 7 0.0007
325 REBOUND EFFECT 8 0.0007
326 FEBRILE BONE MARROW APLASIA 3 0.0007
327 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
328 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
329 GRANULOCYTOPENIA 4 0.0007
330 PRODUCT DISPENSING ISSUE 3 0.0007
331 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
332 BLOOD POTASSIUM DECREASED 21 0.0007
333 PRODUCT USE COMPLAINT 11 0.0007
334 BACTERIAL INFECTION 13 0.0007
335 OCULAR ICTERUS 3 0.0007
336 FEEDING DISORDER 14 0.0007
337 HYPERVENTILATION 4 0.0007
338 DYSPHEMIA 3 0.0007
339 PARONYCHIA 3 0.0007
340 ACUTE RESPIRATORY FAILURE 13 0.0007
341 ARTHROPOD BITE 5 0.0007
342 PROTHROMBIN TIME PROLONGED 4 0.0007
343 RESPIRATORY DISORDER 20 0.0007
344 MENINGITIS ASEPTIC 3 0.0007
345 ANAL INCONTINENCE 6 0.0007
346 LETHARGY 38 0.0007
347 ACUTE HEPATIC FAILURE 9 0.0007
348 HAEMOGLOBIN INCREASED 3 0.0007
349 TROPONIN INCREASED 5 0.0007
350 SOMNOLENCE 132 0.0007
351 RENAL FAILURE CHRONIC 5 0.0006
352 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
353 NEPHROGENIC ANAEMIA 3 0.0006
354 CONVULSION 37 0.0006
355 PHARYNGITIS STREPTOCOCCAL 7 0.0006
356 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
357 PANCREATITIS 34 0.0006
358 APPENDICITIS 6 0.0006
359 AGGRESSION 32 0.0006
360 SKIN TIGHTNESS 3 0.0006
361 AFFECTIVE DISORDER 5 0.0006
362 SLEEP APNOEA SYNDROME 12 0.0006
363 HEPATIC CYTOLYSIS 8 0.0006
364 CARDIOGENIC SHOCK 9 0.0006
365 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
366 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
367 SKIN INFECTION 7 0.0006
368 HUMERUS FRACTURE 3 0.0006
369 ENTEROCOCCAL INFECTION 3 0.0006
370 INFUSION SITE PAIN 8 0.0006
371 FRUSTRATION TOLERANCE DECREASED 5 0.0006
372 HEPATIC FUNCTION ABNORMAL 23 0.0006
373 STAPHYLOCOCCAL SEPSIS 3 0.0006
374 APPETITE DISORDER 4 0.0006
375 FEBRILE NEUTROPENIA 40 0.0006
376 FLUID INTAKE REDUCED 3 0.0006
377 SEPTIC SHOCK 26 0.0006
378 DYSKINESIA 24 0.0006
379 INSURANCE ISSUE 9 0.0006
380 HOSPITALISATION 90 0.0006
381 HEPATIC CIRRHOSIS 11 0.0006
382 INITIAL INSOMNIA 6 0.0006
383 EYE MOVEMENT DISORDER 4 0.0006
384 BLOOD SODIUM DECREASED 11 0.0006
385 CACHEXIA 3 0.0006
386 TONSILLITIS 3 0.0006
387 MALABSORPTION 3 0.0006
388 PNEUMONIA 185 0.0006
389 BLOOD TEST ABNORMAL 8 0.0006
390 IRRITABILITY 34 0.0006
391 INFLUENZA 63 0.0006
392 COMPRESSION FRACTURE 3 0.0006
393 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
394 BRUXISM 3 0.0006
395 OROPHARYNGEAL DISCOMFORT 5 0.0006
396 FAECES SOFT 4 0.0005
397 DRUG LEVEL INCREASED 9 0.0005
398 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
399 GASTRIC ULCER HAEMORRHAGE 3 0.0005
400 VENTRICULAR FIBRILLATION 6 0.0005
401 PERSONALITY CHANGE 5 0.0005
402 SEDATION 14 0.0005
403 PERITONITIS 11 0.0005
404 AGITATION 39 0.0005
405 DECREASED APPETITE 123 0.0005
406 HYPOCALCAEMIA 10 0.0005
407 OSTEOPENIA 8 0.0005
408 DERMATITIS CONTACT 6 0.0005
409 CARDIAC VALVE DISEASE 3 0.0005
410 HYPERTHERMIA 4 0.0005
411 BOWEL MOVEMENT IRREGULARITY 4 0.0005
412 FEMUR FRACTURE 16 0.0005
413 RALES 3 0.0005
414 EATING DISORDER 11 0.0005
415 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
416 HYPOVOLAEMIA 3 0.0005
417 SPLENOMEGALY 6 0.0005
418 SEPSIS 57 0.0005
419 POOR QUALITY SLEEP 11 0.0005
420 MULTIPLE ALLERGIES 4 0.0005
421 THERAPY CHANGE 5 0.0005
422 UNDERDOSE 37 0.0005
423 PYREXIA 175 0.0005
424 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
425 MENTAL STATUS CHANGES 14 0.0005
426 PANCYTOPENIA 28 0.0005
427 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
428 TYPE 1 DIABETES MELLITUS 3 0.0005
429 SENSORY LOSS 4 0.0005
430 VOMITING 233 0.0005
431 HYPOTHERMIA 5 0.0005
432 HEPATOCELLULAR INJURY 7 0.0005
433 DERMATITIS ACNEIFORM 3 0.0005
434 POLYURIA 4 0.0005
435 ABNORMAL FAECES 4 0.0005
436 ANAPHYLACTOID REACTION 2 0.0005
437 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
438 CHOLANGITIS 3 0.0005
439 HYPERTHYROIDISM 7 0.0005
440 JAUNDICE 13 0.0005
441 VENTRICULAR EXTRASYSTOLES 5 0.0005
442 PRE-EXISTING CONDITION IMPROVED 3 0.0005
443 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
444 DEHYDRATION 64 0.0005
445 NEPHROLITHIASIS 22 0.0005
446 SWELLING OF EYELID 3 0.0005
447 PERICARDIAL EFFUSION 11 0.0005
448 CARDIOMYOPATHY 7 0.0005
449 PROTEINURIA 9 0.0005
450 INCONTINENCE 5 0.0005
451 FULL BLOOD COUNT ABNORMAL 5 0.0005
452 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
453 HAEMATURIA 16 0.0005
454 PROCTALGIA 3 0.0005
455 ABNORMAL SENSATION IN EYE 2 0.0005
456 BLOOD MAGNESIUM DECREASED 4 0.0005
457 PRODUCT DOSE OMISSION ISSUE 136 0.0005
458 CARDIAC ARREST 38 0.0005
459 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
460 POLYP 3 0.0005
461 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
462 PURPURA 4 0.0005
463 COVID-19 79 0.0004
464 THERAPY PARTIAL RESPONDER 7 0.0004
465 NERVOUS SYSTEM DISORDER 14 0.0004
466 CARDIOTOXICITY 4 0.0004
467 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
468 HAEMOLYTIC ANAEMIA 4 0.0004
469 ULCER HAEMORRHAGE 3 0.0004
470 LEUKOCYTOSIS 8 0.0004
471 LIP DRY 4 0.0004
472 BLOOD TESTOSTERONE DECREASED 3 0.0004
473 RESTLESSNESS 16 0.0004
474 ENCEPHALITIS 3 0.0004
475 UROSEPSIS 4 0.0004
476 HYPERTRANSAMINASAEMIA 3 0.0004
477 CONJUNCTIVITIS 8 0.0004
478 ELECTROLYTE IMBALANCE 5 0.0004
479 EXTRASYSTOLES 3 0.0004
480 HEPATIC STEATOSIS 8 0.0004
481 MOUTH ULCERATION 9 0.0004
482 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
483 PHOTOPHOBIA 8 0.0004
484 SEASONAL ALLERGY 6 0.0004
485 DIVERTICULUM 3 0.0004
486 FEAR OF INJECTION 3 0.0004
487 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
488 INCREASED APPETITE 8 0.0004
489 CELLULITIS 21 0.0004
490 ASPARTATE AMINOTRANSFERASE INCREASED 22 0.0004
491 HYPOKALAEMIA 19 0.0004
492 NEURALGIA 10 0.0004
493 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
494 THROMBOTIC MICROANGIOPATHY 4 0.0004
495 ILLNESS 42 0.0004
496 LIVER INJURY 10 0.0004
497 HYPOTHYROIDISM 13 0.0004
498 HYPERCALCAEMIA 5 0.0004
499 LACTIC ACIDOSIS 13 0.0004
500 SALIVARY HYPERSECRETION 4 0.0004
501 RESPIRATORY ARREST 11 0.0004
502 SLEEP DISORDER 28 0.0004
503 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
504 BRAIN OEDEMA 5 0.0004
505 PLATELET COUNT DECREASED 42 0.0004
506 BONE MARROW FAILURE 8 0.0004
507 URINARY RETENTION 13 0.0004
508 FOOD ALLERGY 3 0.0004
509 URINARY TRACT INFECTION 66 0.0004
510 EJECTION FRACTION DECREASED 6 0.0004
511 PELVIC FRACTURE 3 0.0004
512 PULMONARY HYPERTENSION 8 0.0004
513 GASTROINTESTINAL INFLAMMATION 3 0.0004
514 CARDIO-RESPIRATORY ARREST 16 0.0004
515 HEPATIC ENZYME INCREASED 26 0.0004
516 HEAD INJURY 12 0.0004
517 FURUNCLE 3 0.0004
518 CONSTIPATION 82 0.0004
519 SURGERY 22 0.0004
520 ANAL FISTULA 2 0.0004
521 TRANSPLANT REJECTION 3 0.0004
522 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
523 ANAL ABSCESS 2 0.0004
524 FIBROMYALGIA 9 0.0004
525 FREQUENT BOWEL MOVEMENTS 10 0.0004
526 SINUS CONGESTION 5 0.0004
527 SHOCK HAEMORRHAGIC 3 0.0004
528 SKIN LACERATION 4 0.0004
529 PRODUCT DISPENSING ERROR 8 0.0004
530 MOOD ALTERED 10 0.0004
531 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
532 TOOTH FRACTURE 4 0.0004
533 THERAPEUTIC RESPONSE DECREASED 22 0.0004
534 DENTAL CARIES 4 0.0004
535 CARDIAC FAILURE 29 0.0004
536 SINUSITIS 37 0.0004
537 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
538 LIVER DISORDER 16 0.0004
539 TRANSAMINASES INCREASED 8 0.0004
540 INFECTION 52 0.0004
541 OCULAR DISCOMFORT 4 0.0004
542 OXYGEN SATURATION DECREASED 20 0.0004
543 BLOOD CALCIUM DECREASED 4 0.0004
544 CANDIDA INFECTION 6 0.0004
545 DEVICE OCCLUSION 5 0.0004
546 ANGER 12 0.0004
547 EYE INFECTION 4 0.0004
548 HEMIPARESIS 6 0.0004
549 OFF LABEL USE 310 0.0004
550 HAEMATOCRIT DECREASED 7 0.0004
551 FACIAL PARALYSIS 3 0.0004
552 VITAMIN D DECREASED 3 0.0004
553 INTENTIONAL DOSE OMISSION 10 0.0004
554 DRUG-INDUCED LIVER INJURY 11 0.0004
555 PSEUDOMONAS INFECTION 3 0.0003
556 RED BLOOD CELL COUNT DECREASED 10 0.0003
557 CARDIAC OPERATION 3 0.0003
558 TACHYCARDIA 31 0.0003
559 ANURIA 3 0.0003
560 EYE IRRITATION 20 0.0003
561 MULTI-ORGAN FAILURE 6 0.0003
562 PRODUCT ADMINISTRATION ERROR 7 0.0003
563 PYELONEPHRITIS 3 0.0003
564 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
565 ABDOMINAL DISTENSION 36 0.0003
566 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
567 NEUTROPHIL COUNT DECREASED 14 0.0003
568 VASCULITIS 4 0.0003
569 WHITE BLOOD CELL COUNT DECREASED 37 0.0003
570 TUMOUR LYSIS SYNDROME 3 0.0003
571 PRODUCT COMMUNICATION ISSUE 3 0.0003
572 LABORATORY TEST ABNORMAL 10 0.0003
573 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
574 URINARY INCONTINENCE 10 0.0003
575 BLOOD CREATININE INCREASED 22 0.0003
576 EYE PAIN 19 0.0003
577 NASOPHARYNGITIS 62 0.0003
578 IMMUNODEFICIENCY 5 0.0003
579 GASTROINTESTINAL DISORDER 30 0.0003
580 GASTROINTESTINAL INFECTION 3 0.0003
581 APHASIA 10 0.0003
582 PNEUMONITIS 9 0.0003
583 NOCTURIA 4 0.0003
584 OEDEMA PERIPHERAL 40 0.0003
585 DIARRHOEA 211 0.0003
586 PRODUCT USE IN UNAPPROVED INDICATION 81 0.0003
587 WEIGHT DECREASED 91 0.0003
588 MUSCLE SPASTICITY 4 0.0003
589 CARDIOMEGALY 4 0.0003
590 ANKLE FRACTURE 5 0.0003
591 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
592 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
593 THROMBOCYTOPENIA 36 0.0003
594 LUNG INFECTION 5 0.0003
595 ERYTHEMA MULTIFORME 3 0.0003
596 HAEMOGLOBIN DECREASED 33 0.0003
597 ABORTION INDUCED 3 0.0003
598 INTESTINAL OBSTRUCTION 12 0.0003
599 MUSCULAR WEAKNESS 36 0.0003
600 COLITIS 12 0.0003
601 SPUTUM DISCOLOURED 3 0.0003
602 MUSCLE ATROPHY 4 0.0003
603 NEUROPATHY PERIPHERAL 30 0.0003
604 COMA 15 0.0003
605 PULMONARY OEDEMA 14 0.0003
606 SENSORY DISTURBANCE 5 0.0003
607 MOVEMENT DISORDER 10 0.0003
608 HYPERCHOLESTEROLAEMIA 3 0.0003
609 CHROMATURIA 7 0.0003
610 UNRESPONSIVE TO STIMULI 8 0.0003
611 AUTOIMMUNE DISORDER 3 0.0003
612 PARKINSONISM 3 0.0003
613 HAEMORRHOIDS 6 0.0003
614 TREMOR 51 0.0003
615 PLATELET COUNT INCREASED 4 0.0003
616 NASAL CONGESTION 18 0.0003
617 BODY TEMPERATURE DECREASED 3 0.0003
618 LIGAMENT SPRAIN 3 0.0003
619 CRYING 11 0.0003
620 RECTAL HAEMORRHAGE 13 0.0003
621 BLOOD PRESSURE DECREASED 20 0.0003
622 BRAIN INJURY 3 0.0003
623 WEIGHT INCREASED 67 0.0003
624 EMPHYSEMA 3 0.0003
625 FACE OEDEMA 5 0.0003
626 DRUG LEVEL DECREASED 3 0.0003
627 MOTOR DYSFUNCTION 3 0.0003
628 DISEASE RECURRENCE 14 0.0003
629 BODY TEMPERATURE INCREASED 6 0.0003
630 IMPAIRED GASTRIC EMPTYING 4 0.0003
631 ABNORMAL LOSS OF WEIGHT 2 0.0003
632 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
633 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
634 PERIPHERAL COLDNESS 4 0.0003
635 MUSCULOSKELETAL DISCOMFORT 5 0.0003
636 TENDERNESS 3 0.0003
637 PETECHIAE 3 0.0003
638 WEIGHT FLUCTUATION 3 0.0003
639 PRODUCT ODOUR ABNORMAL 3 0.0003
640 TRANSFUSION 3 0.0003
641 HEART RATE DECREASED 10 0.0003
642 HALLUCINATION, VISUAL 6 0.0003
643 HYPONATRAEMIA 16 0.0003
644 SUDDEN DEATH 3 0.0003
645 RENAL PAIN 3 0.0003
646 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
647 FLATULENCE 16 0.0003
648 THIRST 5 0.0003
649 LIVER FUNCTION TEST INCREASED 6 0.0003
650 ANGINA PECTORIS 8 0.0003
651 COUGH 78 0.0003
652 DRUG INTERACTION 44 0.0003
653 OEDEMA 15 0.0003
654 OSTEOMYELITIS 5 0.0003
655 ABDOMINAL PAIN 64 0.0003
656 RESTLESS LEGS SYNDROME 5 0.0003
657 FLUID OVERLOAD 4 0.0003
658 END STAGE RENAL DISEASE 5 0.0003
659 CONDITION AGGRAVATED 83 0.0003
660 APPLICATION SITE PAIN 6 0.0003
661 MEDICATION ERROR 15 0.0003
662 HEPATOTOXICITY 6 0.0003
663 AGRANULOCYTOSIS 5 0.0003
664 ANAEMIA 51 0.0003
665 EPISTAXIS 20 0.0003
666 SPEECH DISORDER 14 0.0003
667 GASTRITIS 7 0.0003
668 FOOT FRACTURE 5 0.0003
669 BLOOD URINE PRESENT 5 0.0003
670 LOWER LIMB FRACTURE 5 0.0003
671 BLOOD CHOLESTEROL INCREASED 12 0.0003
672 PALLOR 7 0.0003
673 COGNITIVE DISORDER 12 0.0003
674 BRONCHITIS 19 0.0003
675 HYPERKALAEMIA 9 0.0003
676 CHOKING 5 0.0003
677 INSOMNIA 68 0.0003
678 OVERDOSE 55 0.0003
679 CYANOSIS 4 0.0003
680 HYPOTENSION 51 0.0003
681 COVID-19 PNEUMONIA 3 0.0003
682 BLOOD IRON DECREASED 3 0.0003
683 ATAXIA 3 0.0003
684 DISORIENTATION 10 0.0003
685 PNEUMOTHORAX 4 0.0003
686 CHOLECYSTITIS 3 0.0003
687 PRODUCTIVE COUGH 12 0.0003
688 ACCIDENT 3 0.0003
689 SCIATICA 4 0.0003
690 POLYNEUROPATHY 3 0.0003
691 NECK PAIN 14 0.0003
692 WRIST FRACTURE 3 0.0003
693 RENAL FAILURE 33 0.0002
694 C-REACTIVE PROTEIN INCREASED 9 0.0002
695 TASTE DISORDER 5 0.0002
696 BLOOD POTASSIUM INCREASED 4 0.0002
697 STAPHYLOCOCCAL INFECTION 8 0.0002
698 VENTRICULAR TACHYCARDIA 4 0.0002
699 PHARYNGITIS 3 0.0002
700 ACUTE CORONARY SYNDROME 2 0.0002
701 FATIGUE 188 0.0002
702 TREATMENT FAILURE 20 0.0002
703 CYTOMEGALOVIRUS INFECTION 4 0.0002
704 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
705 HAEMATOCHEZIA 13 0.0002
706 FALL 78 0.0002
707 IMPAIRED WORK ABILITY 5 0.0002
708 MYDRIASIS 3 0.0002
709 ANOREXIA 3 0.0002
710 ANAPHYLACTIC SHOCK 6 0.0002
711 ABDOMINAL DISCOMFORT 39 0.0002
712 DELIRIUM 8 0.0002
713 NODULE 3 0.0002
714 MENTAL DISORDER 10 0.0002
715 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
716 MELAENA 5 0.0002
717 RENAL IMPAIRMENT 19 0.0002
718 GAIT DISTURBANCE 43 0.0002
719 PANCREATITIS ACUTE 5 0.0002
720 HEART RATE INCREASED 22 0.0002
721 DEVICE BREAKAGE 9 0.0002
722 OSTEOPOROSIS 9 0.0002
723 MUSCLE TWITCHING 5 0.0002
724 RHINORRHOEA 14 0.0002
725 DIVERTICULITIS 6 0.0002
726 PRODUCT DOSE OMISSION 14 0.0002
727 STOMATITIS 13 0.0002
728 MIDDLE INSOMNIA 4 0.0002
729 ABDOMINAL PAIN UPPER 44 0.0002
730 PLEURAL EFFUSION 13 0.0002
731 DISCOMFORT 13 0.0002
732 PRODUCT USE ISSUE 40 0.0002
733 LYMPHOPENIA 3 0.0002
734 FRACTURE 4 0.0002
735 ARRHYTHMIA 10 0.0002
736 LOSS OF CONSCIOUSNESS 27 0.0002
737 FUNGAL INFECTION 7 0.0002
738 FEELING JITTERY 4 0.0002
739 SYNCOPE 21 0.0002
740 PARALYSIS 3 0.0002
741 GAIT INABILITY 7 0.0002
742 BALANCE DISORDER 18 0.0002
743 DIABETIC KETOACIDOSIS 5 0.0002
744 CONTUSION 20 0.0002
745 GLAUCOMA 4 0.0002
746 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
747 LOCALISED INFECTION 5 0.0002
748 HYPOGLYCAEMIA 10 0.0002
749 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
750 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
751 ORAL HERPES 4 0.0002
752 KIDNEY INFECTION 4 0.0002
753 ACUTE MYOCARDIAL INFARCTION 6 0.0002
754 BLOOD PRESSURE INCREASED 31 0.0002
755 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
756 DISABILITY 4 0.0002
757 DYSPHAGIA 19 0.0002
758 DEEP VEIN THROMBOSIS 13 0.0002
759 SPINAL FRACTURE 4 0.0002
760 CYTOKINE RELEASE SYNDROME 4 0.0002
761 LACRIMATION INCREASED 6 0.0002
762 ECONOMIC PROBLEM 3 0.0002
763 TOXICITY TO VARIOUS AGENTS 33 0.0002
764 HEPATITIS 5 0.0002
765 PRODUCT PREPARATION ERROR 4 0.0002
766 THYROID DISORDER 3 0.0002
767 EMOTIONAL DISORDER 6 0.0002
768 RIB FRACTURE 4 0.0002
769 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
770 INTENTIONAL PRODUCT MISUSE 17 0.0002
771 LIMB DISCOMFORT 6 0.0002
772 MUSCULOSKELETAL CHEST PAIN 3 0.0002
773 DELUSION 3 0.0002
774 BRAIN FOG 3 0.0002
775 NERVOUSNESS 10 0.0002
776 PRODUCT SUBSTITUTION ISSUE 11 0.0002
777 ADVERSE DRUG REACTION 17 0.0002
778 DYSPNOEA 107 0.0002
779 MOOD SWINGS 6 0.0002
780 CARDIAC FAILURE CONGESTIVE 15 0.0002
781 DRUG INTOLERANCE 18 0.0002
782 DISTURBANCE IN ATTENTION 10 0.0002
783 BACK DISORDER 3 0.0002
784 ADVERSE EVENT 17 0.0002
785 LIMB INJURY 5 0.0002
786 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
787 TREATMENT NONCOMPLIANCE 10 0.0002
788 GENERAL PHYSICAL HEALTH DETERIORATION 21 0.0002
789 ABNORMAL DREAMS 5 0.0002
790 MUSCLE SPASMS 33 0.0002
791 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
792 RASH PAPULAR 4 0.0002
793 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
794 MIGRAINE 17 0.0002
795 PARAESTHESIA 28 0.0002
796 DISEASE PROGRESSION 21 0.0002
797 HEART RATE IRREGULAR 4 0.0002
798 NEUTROPENIA 24 0.0002
799 PRODUCT AVAILABILITY ISSUE 4 0.0002
800 ASTHENIA 66 0.0002
801 INFLAMMATION 9 0.0002
802 THROMBOSIS 14 0.0002
803 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
804 MUSCULOSKELETAL STIFFNESS 15 0.0002
805 NEUROTOXICITY 3 0.0002
806 CHRONIC KIDNEY DISEASE 13 0.0002
807 NAUSEA 135 0.0002
808 PSYCHOTIC DISORDER 5 0.0002
809 DRUG ERUPTION 3 0.0002
810 PERIPHERAL SWELLING 26 0.0002
811 OCULAR HYPERAEMIA 8 0.0002
812 PULMONARY EMBOLISM 16 0.0002
813 POLLAKIURIA 7 0.0002
814 GOUT 3 0.0002
815 BLOOD GLUCOSE DECREASED 8 0.0002
816 CORONARY ARTERY DISEASE 5 0.0002
817 ILL-DEFINED DISORDER 10 0.0002
818 CEREBRAL INFARCTION 4 0.0002
819 LUNG DISORDER 8 0.0002
820 DYSURIA 6 0.0002
821 RASH 71 0.0002
822 THINKING ABNORMAL 3 0.0002
823 AGEUSIA 4 0.0002
824 DRY EYE 8 0.0002
825 LEUKOPENIA 8 0.0002
826 INFLUENZA LIKE ILLNESS 13 0.0002
827 HAEMATEMESIS 4 0.0002
828 CARDIOVASCULAR DISORDER 4 0.0002
829 CHEST DISCOMFORT 16 0.0002
830 POST PROCEDURAL COMPLICATION 3 0.0002
831 HYPERTENSION 33 0.0002
832 HIP FRACTURE 5 0.0002
833 ERUCTATION 3 0.0002
834 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
835 ANXIETY 44 0.0002
836 MEMORY IMPAIRMENT 21 0.0002
837 CHOLELITHIASIS 5 0.0002
838 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
839 SINUS DISORDER 3 0.0002
840 OROPHARYNGEAL PAIN 14 0.0002
841 BLOOD PRESSURE ABNORMAL 3 0.0002
842 UPPER LIMB FRACTURE 3 0.0002
843 LIP SWELLING 5 0.0001
844 DRUG INEFFECTIVE 196 0.0001
845 BLOOD GLUCOSE INCREASED 28 0.0001
846 RASH PRURITIC 8 0.0001
847 MYALGIA 25 0.0001
848 FEELING HOT 9 0.0001
849 HEADACHE 92 0.0001
850 RASH ERYTHEMATOUS 7 0.0001
851 HOT FLUSH 11 0.0001
852 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
853 GASTRIC DISORDER 5 0.0001
854 HAEMOPTYSIS 4 0.0001
855 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
856 WITHDRAWAL SYNDROME 6 0.0001
857 BURNING SENSATION 10 0.0001
858 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
859 LYMPHADENOPATHY 5 0.0001
860 PAIN IN JAW 4 0.0001
861 DEATH 121 0.0001
862 JOINT INJURY 3 0.0001
863 HYPOAESTHESIA 21 0.0001
864 THERAPY INTERRUPTED 10 0.0001
865 IRRITABLE BOWEL SYNDROME 3 0.0001
866 CEREBRAL HAEMORRHAGE 5 0.0001
867 SWELLING 13 0.0001
868 SWELLING FACE 9 0.0001
869 LIVER FUNCTION TEST ABNORMAL 4 0.0001
870 ACUTE KIDNEY INJURY 21 0.0001
871 DYSSTASIA 4 0.0001
872 BONE PAIN 8 0.0001
873 DIZZINESS 68 0.0001
874 INFUSION RELATED REACTION 9 0.0001
875 CHEST PAIN 25 0.0001
876 STEVENS-JOHNSON SYNDROME 3 0.0001
877 WHEEZING 8 0.0001
878 DYSGEUSIA 10 0.0001
879 CATARACT 8 0.0001
880 THROAT IRRITATION 6 0.0001
881 FEELING ABNORMAL 32 0.0001
882 THERAPY NON-RESPONDER 6 0.0001
883 NO ADVERSE EVENT 24 0.0001
884 ACNE 10 0.0001
885 DIABETES MELLITUS 10 0.0001
886 TINNITUS 6 0.0001
887 SKIN DISCOLOURATION 6 0.0001
888 DRUG ADMINISTRATION ERROR 4 0.0001
889 HYPERSENSITIVITY 24 0.0001
890 RENAL DISORDER 6 0.0001
891 PALPITATIONS 15 0.0001
892 ANAPHYLACTIC REACTION 7 0.0001
893 BLISTER 7 0.0001
894 CONFUSIONAL STATE 20 0.0001
895 EXTRA DOSE ADMINISTERED 5 0.0001
896 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
897 ATRIAL FIBRILLATION 12 0.0001
898 BLINDNESS 5 0.0001
899 DEVICE ISSUE 11 0.0001
900 OSTEONECROSIS 4 0.0001
901 SKIN DISORDER 4 0.0001
902 UNEVALUABLE EVENT 9 0.0001
903 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
904 ABDOMINAL PAIN LOWER 3 0.0001
905 FLUID RETENTION 6 0.0001
906 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
907 HYPERHIDROSIS 15 0.0001
908 SKIN ULCER 3 0.0001
909 DRUG DOSE OMISSION BY DEVICE 9 0.0001
910 HAEMORRHAGE 12 0.0001
911 ANHEDONIA 3 0.0001
912 DEPRESSED MOOD 6 0.0001
913 BRADYCARDIA 6 0.0001
914 ANGIOEDEMA 5 0.0001
915 MALAISE 49 0.0001
916 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
917 MOBILITY DECREASED 8 0.0001
918 DRY MOUTH 9 0.0001
919 INCORRECT DOSE ADMINISTERED 25 0.0001
920 SKIN LESION 3 0.0001
921 SKIN IRRITATION 5 0.0001
922 PAIN IN EXTREMITY 32 0.0001
923 FLUSHING 11 0.0001
924 FEELING COLD 3 0.0001
925 URTICARIA 18 0.0001
926 WOUND 3 0.0001
927 CARDIAC DISORDER 10 0.0001
928 TARDIVE DYSKINESIA 3 0.0001
929 HALLUCINATION 8 0.0001
930 PRURITUS 40 0.0001
931 CHILLS 12 0.0001
932 ERYTHEMA 21 0.0001
933 RENAL INJURY 3 0.0001
934 PREMATURE BABY 3 0.0001
935 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
936 THERAPY CESSATION 5 0.0001
937 DEPRESSION 22 0.0001
938 SWOLLEN TONGUE 3 0.0001
939 ROAD TRAFFIC ACCIDENT 4 0.0001
940 ECZEMA 5 0.0001
941 CYSTITIS 3 0.0001
942 NIGHT SWEATS 3 0.0001
943 HYPOACUSIS 4 0.0001
944 DEVICE LEAKAGE 4 0.0001
945 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
946 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
947 ARTHROPATHY 5 0.0001
948 PRODUCT QUALITY ISSUE 12 0.0001
949 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
950 ALOPECIA 17 0.0001
951 PAIN 53 0.0001
952 NEOPLASM PROGRESSION 3 0.0001
953 BACK PAIN 20 0.0001
954 DYSPHONIA 5 0.0001
955 DEVICE MALFUNCTION 6 0.0001
956 MULTIPLE SCLEROSIS 4 0.0001
957 CEREBROVASCULAR ACCIDENT 14 0.0001
958 EMOTIONAL DISTRESS 10 0.0001
959 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
960 VERTIGO 5 0.0001
961 ARTHRALGIA 34 0.0001
962 DYSARTHRIA 3 0.0001
963 INJECTION SITE SWELLING 6 0.0001
964 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
965 INTENTIONAL OVERDOSE 5 0.0001
966 AMNESIA 5 0.0001
967 SUICIDAL IDEATION 7 0.0001
968 DRY SKIN 10 0.0001
969 JOINT SWELLING 9 0.0001
970 PSORIATIC ARTHROPATHY 3 0.0001
971 VISION BLURRED 10 0.0001
972 VISUAL IMPAIRMENT 9 0.0001
973 DRUG DOSE OMISSION 12 0.0001
974 DYSPEPSIA 7 0.0001
975 INJURY 5 0.0001
976 OSTEOARTHRITIS 3 0.0001
977 HERPES ZOSTER 4 0.0001
978 VAGINAL HAEMORRHAGE 3 0.0001
979 DEVICE DISLOCATION 3 0.0001
980 MYOCARDIAL INFARCTION 12 0.0001
981 EXPOSURE DURING PREGNANCY 4 0.0001
982 INTERSTITIAL LUNG DISEASE 3 0.0001
983 ASTHMA 6 0.0001
984 ARTHRITIS 4 0.0001
985 INJECTION SITE BRUISING 4 0.0001
986 INJECTION SITE ERYTHEMA 6 0.0000
987 SKIN EXFOLIATION 4 0.0000
988 PSORIASIS 6 0.0000
989 DRUG WITHDRAWAL SYNDROME 4 0.0000
990 INJECTION SITE PRURITUS 3 0.0000
991 INJECTION SITE HAEMORRHAGE 3 0.0000
992 PROSTATE CANCER 3 0.0000
993 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
994 INJECTION SITE PAIN 8 0.0000